| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 171.711.411 $ | +77.544.946 $ | +476,8 % | 68.957.263 $ | +20.454.982 $ | +10.555,7 % | 13.458.653 $ | +10.103.355 $ | +307,8 % | |
| RA CAPITAL MANAGEMENT, L.P. | 23.785.080 $ | +6.321.260 $ | +36,2 % | 17.463.820 $ | |||||
| Janus Henderson Group Ltd. | 23.731.510 $ | ||||||||
| Affinity Asset Advisors, LLC | 23.612.626 $ | +11.958.126 $ | +102,6 % | 11.654.500 $ | +8.209.500 $ | +238,3 % | |||
| EVENTIDE ASSET MANAGEMENT, LLC | 22.015.542 $ | +15.030.992 $ | +215,2 % | 6.984.550 $ | |||||
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 13.683.594 $ | +7.991.634 $ | +140,4 % | 5.691.960 $ | +3.936.960 $ | +224,3 % | |||
| BALYASNY ASSET MANAGEMENT L.P. | 12.283.422 $ | +11.753.672 $ | +2.218,7 % | ||||||
| ADAR1 Capital Management, LLC | 10.087.931 $ | +3.103.381 $ | +44,4 % | 6.984.550 $ | +6.967.850 $ | +41.723,7 % | |||
| TAKEDA PHARMACEUTICAL CO LTD | 9.791.595 $ | +7.306.215 $ | +294,0 % | ||||||
| Saturn V Capital Management LP | 9.249.999 $ | +5.174.999 $ | +127,0 % | 4.075.000 $ | |||||
| FEDERATED HERMES, INC. | 7.927.620 $ | +2.620.807 $ | +49,4 % | 5.306.813 $ | |||||
| Ikarian Capital, LLC | 6.426.242 $ | +6.022.722 $ | +1.492,5 % | ||||||
| Ally Bridge Group (NY) LLC | 6.256.979 $ | +3.347.429 $ | +115,0 % | ||||||
| Point72 Asset Management, L.P. | 5.788.340 $ | ||||||||
| VANGUARD GROUP INC | 5.007.730 $ | +1.340.672 $ | +36,6 % | 3.667.058 $ | +2.797.140 $ | +321,5 % | |||
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4.819.829 $ | +4.219.924 $ | +703,4 % | ||||||
| Blue Owl Capital Holdings LP | 4.228.359 $ | ||||||||
| SPHERA FUNDS MANAGEMENT LTD. | 3.602.678 $ | ||||||||
| 171.711.411 $ | +77.544.946 $ | +476,8 % | 68.957.263 $ | +20.454.982 $ | +10.555,7 % | 13.458.653 $ | +10.103.355 $ | +307,8 % | |